Clinical Trial Update: Neo-adjuvant Pembrolizumab in Primary Stage IV Ovarian Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating neo-adjuvant pembrolizumab in primary stage IV ovarian cancer with peritoneal or fallopian tube involvement. The study status is comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: The Netherlands Cancer Institute | Conditions: Ovarian Cancer Stage IV, Peritoneal Cancer | Phase 1, Phase 2 | Status: COMPLETED